info@seagull-health.com
SeagullHealth
语言:
search

How should I use Krazati(Adagrasib)?

The recommended dose is 600 mg orally, twice daily, for both NSCLC (as a single agent) and CRC (in combination with cetuximab). 

Dosage and Administration

The recommended dosage for Adagrasib is:

NSCLC: 600 mg twice daily as a single agent.

CRC: 600 mg twice daily when used with cetuximab.

Swallow the tablets whole with or without food. If vomiting occurs after a dose, do not take an additional dose; resume dosing at the next scheduled time. If a dose is missed by more than 4 hours, skip it and continue with the next scheduled dose.

Adagrasib(Krazati)
Adagrasib(Krazati)
Locally advanced or metastatic NSCLC harboring KRAS G12C mutation who have...
WeChat Scan
Free Inquiry
Related articles
Dosage and Administration of Adagrasib
Adagrasib is an irreversible inhibitor of KRASG12C mutation, mainly used for the treatment of non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with specific gene mutations.Dosage and Adm...
Usage and Dosage of Adagrasib
Adagrasib is a targeted drug for the treatment of non-small cell lung cancer (NSCLC) with KRAS G12C mutation. It blocks the growth and spread of diseased cells by inhibiting the activity of KRAS G12C ...
共 2 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved